Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Klarenbeek, C. Allaart, P. Kerstens, T. Huizinga, B. Dijkmans (2009)
The BeSt story: on strategy trials in rheumatoid arthritisCurrent Opinion in Rheumatology, 21
L. Tuyl, W. Lems, A. Voskuyl, P. Kerstens, P. Garnero, B. Dijkmans, M. Boers (2008)
Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trialAnnals of the Rheumatic Diseases, 67
J. Fransen, R. Laan, M. Laar, T. Huizinga, P. Riel (2004)
Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritisAnnals of the Rheumatic Diseases, 63
B. Combe, R. Landewé, C. Lukas, Horatio Bolosiu, F. Breedveld, M. Dougados, P. Emery, G. Ferraccioli, J. Hazes, Lars Klareskog, K. Machold, E. Martı́n-Mola, H. Nielsen, A. Silman, J. Smolen, H. Yazici (2006)
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 66
Richard Grol, J. Grimshaw, C. Weel (2003)
From best evidence to best practice: effective implementation of change in patients' care. CommentaryThe Lancet, 362
S. Proudman, H. Keen, L. Stamp, Anita Lee, F. Goldblatt, Oliver Ayres, M. Rischmueller, M. James, C. Hill, G. Caughey, L. Cleland (2007)
Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.Seminars in arthritis and rheumatism, 37 2
Jennifer Anderson, G. Wells, A. Verhoeven, D. Felson (2000)
Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.Arthritis and rheumatism, 43 1
H. Dongen, J. Aken, L. Lard, K. Visser, H. Ronday, H. Hulsmans, I. Speyer, M. Westedt, A. Peeters, C. Allaart, R. Toes, F. Breedveld, Tom Huizinga (2007)
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial.Arthritis and rheumatism, 56 5
S. Ryan, A. Hassell, Martyn Lewis, Adrian Farrell (2006)
Impact of a rheumatology expert nurse on the wellbeing of patients attending a drug monitoring clinic.Journal of advanced nursing, 53 3
J. Higgins, S. Thompson (2002)
Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 21
C. Grigor, H. Capell, A. Stirling, A. McMahon, Peter Lock, R. Vallance, D. Porter, W. Kincaid (2004)
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trialThe Lancet, 364
Jaap Fransen, Gerold Stucki, Jos Twisk, Chamot Am, J. Gerster, T. Langenegger, M. Seitz, Beat Michel (2003)
Effectiveness of a measurement feedback system on outcome in rheumatoid arthritis: a controlled clinical trialAnnals of the Rheumatic Diseases, 62
R. Dersimonian, R. Dersimonian, N. Laird, N. Laird (1986)
Meta-analysis in clinical trials.Controlled clinical trials, 7 3
P. Kiely, A. Brown, C. Edwards, D. O’Reilly, A. Ostör, Mark Quinn, A. Taggart, P. Taylor, R. Wakefield, P. Conaghan (2009)
Contemporary treatment principles for early rheumatoid arthritis: a consensus statement.Rheumatology, 48 7
D. Symmons, K. Tricker, Mark Harrison, Chris Roberts, M. Davis, P. Dawes, Andrew Hassell, Samantha Knight, D. Mulherin, David Scott (2006)
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial.Rheumatology, 45 5
G. Tijhuis, A. Zwinderman, J. Hazes, F. Breedveld, Theodora Vlieland (2003)
Two-year follow-up of a randomized controlled trial of a clinical nurse specialist intervention, inpatient, and day patient team care in rheumatoid arthritis.Journal of advanced nursing, 41 1
F. Arnett, S. Edworthy, D. Bloch, D. McShane, J. Fries, N. Cooper, L. Healey, S. Kaplan, M. Liang, H. Luthra, T. Medsger, D. Mitchell, D. Neustadt, R. Pinals, J. Schaller, J. Sharp, R. Wilder, G. Hunder (1988)
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis and rheumatism, 31 3
J. Berlin, N. Laird, H. Sacks, T. Chalmers (1989)
A comparison of statistical methods for combining event rates from clinical trials.Statistics in medicine, 8 2
S. Saunders, H. Capell, A. Stirling, R. Vallance, Wilma Kincaid, Alex McMahon, Duncan Porter (2008)
Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.Arthritis and rheumatism, 58 5
Y. Goekoop-Ruiterman, J. Vries-Bouwstra, P. Kerstens, M. Nielen, K. Vos, D. Schaardenburg, I. Speyer, P. Seys, F. Breedveld, C. Allaart, B. Dijkmans (2009)
DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritisAnnals of the Rheumatic Diseases, 69
D. Symmons, K. Tricker, C. Roberts, L. Davies, P. Dawes, David Scott (2005)
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis.Health technology assessment, 9 34
L. Hulst, M. Creemers, J. Fransen, Linda Li, R. Grol, M. Hulscher, P. Riel (2010)
How to improve DAS28 use in daily clinical practice?--a pilot study of a nurse-led intervention.Rheumatology, 49 4
J. Fransen, H. Moens, I. Speyer, P. Riel (2005)
Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trialAnnals of the Rheumatic Diseases, 64
S. Verstappen, J. Jacobs, J. Jacobs, M. Veen, A. Heurkens, Y. Schenk, E. Borg, A. Blaauw, J. Bijlsma (2007)
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)Annals of the Rheumatic Diseases, 66
A. Finckh, M. Liang, Carmen Herckenrode, P. Pablo (2006)
Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis.Arthritis and rheumatism, 55 6
G. Tijhuis, A. Zwinderman, J. Hazes, W. Hout, F. Breedveld, T. Vlieland (2002)
A randomized comparison of care provided by a clinical nurse specialist, an inpatient team, and a day patient team in rheumatoid arthritis.Arthritis and rheumatism, 47 5
R. Grol, J. Grimshaw, R. Grol, J. Grimshaw
For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. from Best Evidence to Best Practice: Effective Implementation of Change in Patients' Care
S. Hewlett, J. Kirwan, J. Pollock, K. Mitchell, M. Hehir, P. Blair, D. Memel, M. Perry (2004)
Patient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trialBMJ : British Medical Journal, 330
D. Heijde, M. Hof, P. Riel, L. Putte (1993)
Development of a disease activity score based on judgment in clinical practice by rheumatologists.The Journal of rheumatology, 20 3
M. Prevoo, M. Hof, H. Kuper, M. Leeuwen, L. Putte, P. Riel (1995)
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.Arthritis and rheumatism, 38 1
J. Higgins, S. Thompson, J. Deeks, D. Altman (2003)
Measuring inconsistency in meta-analysesBMJ : British Medical Journal, 327
M. Cabana, C. Rand, N. Powe, A. Wu, Modena Wilson, P. Abboud, H. Rubin (1999)
Why don't physicians follow clinical practice guidelines? A framework for improvement.JAMA, 282 15
M. Bakker, J. Jacobs, S. Verstappen, J. Bijlsma (2007)
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibilityAnnals of the Rheumatic Diseases, 66
A. Gestel, M. Prevoo, M. Hof, M. Rijswijk, L. Putte, P. Riel (1996)
Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria.Arthritis and rheumatism, 39 1
T. Vlieland, F. Breedveld, J. Hazes (1997)
The two-year follow-up of a randomized comparison of in-patient multidisciplinary team care and routine out-patient care for active rheumatoid arthritis.British journal of rheumatology, 36 1
A. Gestel, C. Haagsma, P. Riel (1998)
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts.Arthritis and rheumatism, 41 10
Objectives. Tight control studies including regular assessments of disease activity have shown that this approach has beneficial effects on disease activity, disability and joint damage in treating RA patients. Some of these studies included tight control with protocolized treatment, while others applied tight control without protocolized treatment. The aim of this study was to compare the effects of tight control with usual care and to compare the effects of tight control studies with and without protocolized treatment adjustments.Methods. A systematic literature search was performed to identify clinical trials in RA that evaluated tight control strategies in comparison with usual care. Two types of study were compared: (i) those using disease activity monitoring with protocolized treatment adjustments, and (ii) those using disease activity monitoring without protocolized treatment adjustments. The databases PubMed and Cochrane were searched from 1995 up to 2009. Primary outcome measure was the mean change in the 28-joint DAS (DAS-28), which was used in a random-effects meta-analysis.Results. Six controlled trials regarding tight control in RA patients were included in the meta-analysis. In all trials, patients treated in the tight control arms had significantly higher DAS-28 responses than patients treated according to usual care [weighted mean difference (WMD)0.59, P<0.001]. Moreover, tight control was significantly more effective (P<0.001) by means of protocolized treatment adjustments (WMD0.97) compared with non-protocolized monitoring of disease activity (WMD0.25).Conclusion. Tight control in RA resulted in significantly better clinical outcomes than usual care. It is suggested but not proved that tight control with protocolized treatment adjustments is more beneficial than if no such protocol is used.
Rheumatology – Oxford University Press
Published: Nov 29, 2010
Keywords: Rheumatoid arthritis Meta-analysis Tight control Treatment adjustments Monitoring
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.